Intellia Therapeutics
Tricia Oliva Millonig has extensive work experience in the pharmaceutical and biotechnology industry. Tricia currently holds the position of VP, Regulatory Project Management and Operations at Intellia Therapeutics, Inc. Prior to this, they worked at 2seventy bio as Sr. Director, Clinical Development Excellence & Business Optimization and Sr. Director, Regulatory Operations & Compliance. Tricia also had notable roles at bluebird bio as Sr. Director, Regulatory Operations & Compliance and Director, Regulatory Operations and Compliance. Earlier in their career, they worked at Biogen as Sr. Manager, Infrastructure & Operations and at Biogen Idec as Service Operations Manager. Tricia started their career at Takeda Pharmaceuticals International Co. as Sr. Systems Engineer and also worked at The Childrens Hospital of Denver as a Systems Administrator. Tricia's career began at Fidelity Investments as a Systems Engineer.
Tricia Oliva Millonig is currently a candidate for a Master of Business Administration degree at the Babson F.W. Olin Graduate School of Business, expected to be completed in 2023. Tricia previously attended Suffolk University from 1997 to 2001.
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.